Alice Guazzelli
Alice Guazzelli
Verified email at edu.salford.ac.uk
Title
Cited by
Cited by
Year
Anti-CTLA-4 therapy for malignant mesothelioma
A Guazzelli, E Bakker, M Krstic-Demonacos, MP Lisanti, F Sotgia, L Mutti
Immunotherapy 9 (3), 273-280, 2017
182017
Tremelimumab for the treatment of malignant mesothelioma
A Guazzelli, M Hussain, M Krstic-Demonacos, L Mutti
Expert opinion on biological therapy 15 (12), 1819-1829, 2015
182015
BAP1 status determines the sensitivity of malignant mesothelioma cells to gemcitabine treatment
A Guazzelli, P Meysami, E Bakker, C Demonacos, A Giordano, ...
International Journal of Molecular Sciences 20 (2), 429, 2019
162019
Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma
A Guazzelli, E Bakker, K Tian, C Demonacos, M Krstic-Demonacos, ...
Expert Opinion on Investigational Drugs 26 (8), 933-944, 2017
132017
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup
E Ciabatti, A Valetto, V Bertini, MI Ferreri, A Guazzelli, S Grassi, F Guerrini, ...
Oncotarget 8 (45), 79188, 2017
102017
Immunotherapy advances for mesothelioma treatment
E Bakker, A Guazzelli, F Ashtiani, C Demonacos, M Krstic-Demonacos, ...
Expert review of anticancer therapy 17 (9), 799-814, 2017
92017
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of …
O Melaiu, C Catalano, C De Santi, M Cipollini, G Figlioli, L Pellè, ...
Genes & cancer 8 (1-2), 438, 2017
82017
Current and prospective pharmacotherapies for the treatment of pleural mesothelioma
E Bakker, A Guazzelli, M Krstic-Demonacos, M Lisanti, F Sotgia, L Mutti
Expert Opinion on Orphan Drugs 5 (6), 455-465, 2017
62017
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification
K Tian, E Bakker, M Hussain, A Guazzelli, H Alhebshi, P Meysami, ...
Journal of translational medicine 16 (1), 282, 2018
42018
What can independent research for mesothelioma achieve to treat this orphan disease?
A Guazzelli, P Meysami, E Bakker, E Bonanni, C Demonacos, ...
Expert Opinion on Investigational Drugs 28 (8), 719-732, 2019
12019
The emerging roles of BAP1 and cancer stem cells in Malignant Mesothelioma
A Guazzelli
University of Salford, 2019
2019
Sirtuin family members selectively regulate autophagy in osteosarcoma and mesothelioma cells in response to cellular stress
R Garva, C Thepmalee, U Yasamut, S Sudsaward, A Guazzelli, ...
Frontiers in oncology 9, 949, 2019
2019
The Treatment of Malignant Pleural Mesothelioma: From the Current Standard to Novel Possible Therapeutic Strategies
E Bakker, A Guazzelli, C Demonacos, M Krstic-Demonacos, L Mutti
Malignant Pleural Mesothelioma, 117-136, 2019
2019
161PDKK1 stabilization as a new malignant pleural mesothelioma therapeutic avenue
A Guazzelli, E Bakker, F Sotgia, M Listanti, M Krstic-Demonacos, L Mutti
Annals of Oncology 28 (suppl_2), 2017
2017
A 14.8 Mb 12p Deletion Disrupting ETV6 in a Patient with Myelodysplastic Syndrome
A Valetto, V Bertini, E Ciabatti, MI Ferreri, A Guazzelli
Hereditary Genet 6 (174), 2161-1041.1000174, 2017
2017
CONVENTIONAL CYTOGENETICS, ACGH, AND PCR AS INTEGRATED WORKUP FOR A CORRECT DIAGNOSIS OF MDS
S GALIMBERTI, E CIABATTI, A Valetto, V Bertini, MI Ferreri, A Guazzelli, ...
2016
Myelodysplastic Syndromes: An Integrated Workup for a Correct Diagnosis
E Ciabatti, A Valetto, V Bertini, S Grassi, F Guerrini, MI Ferreri, A Guazzelli, ...
HAEMATOLOGICA 100, 163-164, 2015
2015
MDS: AN INTEGRATED WORKUP FOR A CORRECT DIAGNOSIS
E Ciabatti, M Ferreri, A Valetto, V Bertini, A Guazzelli, A Azzara, I Petrini, ...
13th International Symposium on Myelodyspastic Syndromes (MDS) 39 (Supplement 1), 2015
2015
Myelodysplastic Syndromes: A Multidisciplinary Integrated Diagnostic Work-up for Patients' Risk Stratification
E Ciabatti, MI Ferreri, A Valetto, A Guazzelli, V Bertini, S Grassi, F Guerrini, ...
Blood, The Journal of the American Society of Hematology 124 (21), 5579-5579, 2014
2014
MYELODYSPLASTIC SYNDROMES: AN INTEGRATED MOLECULAR/CYTOGENETIC WORKUP FOR A CORRECT PATIENTS'RISK STRATIFICATION
S Galimberti, E Ciabatti, S Grassi, MI Ferreri, A Valetto, F Guerrini, ...
HAEMATOLOGICA 99, 345-345, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20